Falsified antimalarials: a minireview - PubMed

Review

Falsified antimalarials: a minireview

Carlos Chaccour et al. Expert Rev Anti Infect Ther. 2015 Apr.

Abstract

Malaria is a curable disease, provided timely access to efficacious drugs is sought. Poor quality and, in particular, falsified antimalarial drugs harm the population of malaria endemic areas; they put lives in peril, cause economic losses to patients, families, industry, and generally undermine the trust in health systems. The extent of the problem is not easily assessed, and although a prevalence of up to 35% of poor-quality antimalarials has been reported, this number should be interpreted with caution given the heterogeneity of methods used to measure it. The trade in falsified antimalarials can be curtailed by putting in place drug quality surveillance, better legislation and improving the access and affordability of these essential drugs.

Keywords: antimalarials; artemisinin; artesunate; counterfeit drugs; falsified drugs; malaria; poor-quality drugs; substandard drugs.

Similar articles

• Relationship between treatment-seeking behaviour and artemisinin drug quality in Ghana.

  Klein EY, Lewis IA, Jung C, Llinás M, Levin SA. Klein EY, et al. Malar J. 2012 Apr 6;11:110. doi: 10.1186/1475-2875-11-110. Malar J. 2012. PMID: 22482747 Free PMC article.

• Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model.

  Jackson KD, Higgins CR, Laing SK, Mwila C, Kobayashi T, Ippolito MM, Sylvia S, Ozawa S. Jackson KD, et al. BMC Public Health. 2020 Jul 9;20(1):1083. doi: 10.1186/s12889-020-08852-w. BMC Public Health. 2020. PMID: 32646393 Free PMC article.

• Poor-quality antimalarials further health inequities in Uganda.

  Evans DR, Higgins CR, Laing SK, Awor P, Ozawa S. Evans DR, et al. Health Policy Plan. 2019 Dec 1;34(Supplement_3):iii36-iii47. doi: 10.1093/heapol/czz012. Health Policy Plan. 2019. PMID: 31816072 Free PMC article.

• Antimalarial drug resistance in Africa: the calm before the storm?

  Conrad MD, Rosenthal PJ. Conrad MD, et al. Lancet Infect Dis. 2019 Oct;19(10):e338-e351. doi: 10.1016/S1473-3099(19)30261-0. Epub 2019 Jul 30. Lancet Infect Dis. 2019. PMID: 31375467 Review.

• Global scenario of counterfeit antimalarials: A potential threat.

  Arora T, Sharma S. Arora T, et al. J Vector Borne Dis. 2019 Oct-Dec;56(4):288-294. doi: 10.4103/0972-9062.302030. J Vector Borne Dis. 2019. PMID: 33269727 Review.

Cited by

• Prevalence of substandard and falsified artemisinin-based combination antimalarial medicines on Bioko Island, Equatorial Guinea.

  Kaur H, Allan EL, Mamadu I, Hall Z, Green MD, Swamidos I, Dwivedi P, Culzoni MJ, Fernandez FM, Garcia G, Hergott D, Monti F. Kaur H, et al. BMJ Glob Health. 2017 Oct 15;2(4):e000409. doi: 10.1136/bmjgh-2017-000409. eCollection 2017. BMJ Glob Health. 2017. PMID: 29082025 Free PMC article.

• Blind-Watermarking-Proof-of-Concept of a Novel Approach to Ensure Batch Traceability for 3D Printed Tablets.

  Windolf H, Chamberlain R, Delmotte A, Quodbach J. Windolf H, et al. Pharmaceutics. 2022 Feb 17;14(2):432. doi: 10.3390/pharmaceutics14020432. Pharmaceutics. 2022. PMID: 35214164 Free PMC article.

• Are we doing enough to prevent poor-quality antimalarial medicines in the developing world?

  Walker EJ, Peterson GM, Grech J, Paragalli E, Thomas J. Walker EJ, et al. BMC Public Health. 2018 May 15;18(1):630. doi: 10.1186/s12889-018-5521-7. BMC Public Health. 2018. PMID: 29764407 Free PMC article.

• Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.

  Ozawa S, Evans DR, Bessias S, Haynie DG, Yemeke TT, Laing SK, Herrington JE. Ozawa S, et al. JAMA Netw Open. 2018 Aug 3;1(4):e181662. doi: 10.1001/jamanetworkopen.2018.1662. JAMA Netw Open. 2018. PMID: 30646106 Free PMC article.

• The diagnostic accuracy of the hand-held Raman spectrometer for the identification of anti-malarial drugs.

  Visser BJ, de Vries SG, Bache EB, Meerveld-Gerrits J, Kroon D, Boersma J, Agnandji ST, van Vugt M, Grobusch MP. Visser BJ, et al. Malar J. 2016 Mar 15;15:160. doi: 10.1186/s12936-016-1212-y. Malar J. 2016. PMID: 26975570 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Medical

  • MedlinePlus Health Information